Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Some DMARDs could cut diabetes risk

By News team

Some disease-modifying antirheumatic drugs (DMARDs) appear to lower the risk of diabetes in patients with rheumatoid arthritis or psoriasis, a retrospective cohort study has found (JAMA 2011;305:2525).

The authors say a randomised controlled trial is now needed to confirm the finding.

The observational study included 13,905 participants. The use of a tumour necrosis factor inhibitor or hydroxychloroquine — but not of methotrexate — was associated with a reduced risk of diabetes mellitus compared with other non-biological DMARDs.

Citation: The Pharmaceutical Journal URI: 11079546

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Popular Medicines

    Popular Medicines

    An illustrated history of some of the most popular branded medicines. Includes colourful historical adverts and details of the medicine's formula and intended purpose.

    £22.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.